SK
Insider
Samuel Kintz
PRESIDENT AND CEOSamuel Kintz (PRESIDENT AND CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $273K of ELVN (12,500 sh × $21.82, as filed), executed Nov 17 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$539K
shares × price, as filed
Last traded
Nov 17 2025
Filed Nov 19 2025
Median ADV $83.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
ELVNRecent filings
ELVNSALE
Enliven Therapeutics, Inc.
View filing →
$758K27,047 sh across 2 lots
Exec Oct 8 2024
Filed Oct 10 2024 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $336K
12,206 sh × $27.51
Exec Oct 4 2024
Filed Oct 8 2024 · 5:30 PM ET